Elucid PlaqueIQ

1. Acquire CTA images of the patient's coronary arteries.

2. Upload the DICOM images to Elucid PlaqueIQ.

3. The software automatically segments and quantifies plaque volume and composition.

4. Review the 3D visualization and quantitative report to assess the extent of calcified, non-calcified, and lipid-rich plaques.

5. Determine the appropriate treatment strategy based on the plaque characteristics, such as medical therapy, PCI, or CABG.

1. Acquire CTA images of the patient's carotid arteries.

2. Upload the DICOM images to Elucid PlaqueIQ.

3. The software analyzes the plaque morphology and identifies high-risk features, such as lipid-rich necrotic core.

4. Review the report to assess the risk of plaque rupture and ischemic stroke.

5. Determine the appropriate treatment strategy based on the plaque characteristics, such as medical therapy or carotid endarterectomy.

1. Acquire CTA images from study participants.

2. Upload the DICOM images to Elucid PlaqueIQ.

3. The software automatically quantifies plaque volume and composition for each patient.

4. Correlate plaque characteristics with clinical outcomes to identify predictors of cardiovascular events.

5. Publish the findings in a peer-reviewed journal.

1. Visualize the plaque type and amount in a patient’s vessels.

2. Assess stable plaque versus more high-risk plaque.

3. Determine the most appropriate therapy based on the patient’s unique plaque composition.

1. PlaqueIQ generates detailed lesion-specific analysis.

2. Risk factors are determined based on plaque composition.

3. A tailored treatment plan is developed based on those risk factors.

1. Acquire CTA images before and after drug treatment.

2. Upload the DICOM images to Elucid PlaqueIQ.

3. The software quantifies plaque volume and composition at both time points.

4. Compare the pre- and post-treatment plaque characteristics to assess drug efficacy.

5. Present the findings at a scientific conference.